We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

bioMérieux

Designs, develops, manufactures and markets in vitro diagnostics systems used in clinical and industrial applications read more Featured Products: More products

Download Mobile App




Multiplex PCR Test Detects Common Viral and Bacterial Causes of Respiratory or Sore Throat Infections in 15 Minutes

By LabMedica International staff writers
Posted on 15 Jul 2024
Print article
Image: The BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini is designed for use on the BIOFIRE® SPOTFIRE® system (Photo courtesy of bioMérieux)
Image: The BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini is designed for use on the BIOFIRE® SPOTFIRE® system (Photo courtesy of bioMérieux)

The COVID-19 pandemic has created the need for healthcare professionals to employ diagnostic tests as close as possible to the patient and provide rapid actionable results. An increasing number of tests are conducted outside hospital labs directly in Emergency Departments (ED) or at the Point of Care (POC). This market is especially active in the U.S. Now, a fast and innovative syndromic testing solution perfectly matches these new medical needs.

bioMérieux’s (Marcy-l’Étoile, France) BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini has obtained U.S. Food and Drug Administration (FDA) Special 510(k) clearance and CLIA-waiver (Clinical Laboratory Improvement Amendments). Designed for use on the BIOFIRE® SPOTFIRE® system, the BIOFIRE® SPOTFIRE® R/ST Panel Mini is a unique multiplex PCR test that detects five of the most common viral and bacterial causes of respiratory or sore throat infections in around 15 minutes. Samples can be taken from a nasopharyngeal swab when a respiratory tract infection is suspected or from a throat swab when pharyngitis is suspected. When implementing decentralized testing, CLIA-waiver is vital as it allows for the use of this system and panels by non-lab professionals in POC settings where patients require care such as urgent care, physician offices, local pharmacies, student health clinics, or emergency departments.

The BIOFIRE® SPOTFIRE® system is a unique POC platform that delivers fast results and offers flexibility with the capability to run either a large multiplex respiratory test with up to 15 pathogens with the BIOFIRE® SPOTFIRE® R/ST Panel, already FDA-cleared and CLIA-waived, or a small multiplex respiratory test with five pathogens with the BIOFIRE® SPOTFIRE® R/ST Panel Mini. This flexibility enables clinicians to select the appropriate test for their patients. The BIOFIRE® SPOTFIRE® R/ST Panel Mini has become the fourth panel of the BIOFIRE® SPOTFIRE® range to achieve FDA clearance and CLIA waiver. bioMérieux will make the new BIOFIRE® SPOTFIRE® R/ST Panel Mini available in the third quarter of 2024 in the U.S. bioMérieux intends to commercialize the BIOFIRE® SPOTFIRE® R/ST Panel Mini along with the larger multiplex BIOFIRE® SPOTFIRE® R/ST Panel to further expand its presence in the North American outpatient market.

“The medical community continues to bring enhanced technology closer to patients, allowing clinicians to have more information to make real-time decisions,” said Dr Charles K. Cooper, Executive Vice-President and Chief Medical Officer. “Regarding strep throat, Group A Streptococcus accounts for approximately 20% of sore throat cases and has historically been diagnosed via antigen tests. Including it on this PCR panel with common viral causes of strep throat, including rhinovirus, represents a step forward in healthcare, ultimately increasing diagnostic yield and removing the need to reflex to culture in most patients.”

“With our BIOFIRE® SPOTFIRE® R/ST Panel Mini, we bring a fast, highly sensitive, and targeted panel to test for 4 of the most common respiratory viruses (including influenzas) and Streptococcus A, from one throat swab, all at the same time,” added Jennifer Zinn, Executive Vice President, Clinical Operations. “Our offer meets the current needs of the growing decentralized, POC market bringing syndromic testing to the frontline of patient care. With this innovation, clinicians now can confidently tell their patients quickly what is making them sick and get them on the right treatment pathway, limiting the overuse of antibiotics.”

New
Gold Member
Veterinary Hematology Analyzer
Exigo H400
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
New
Strongyloides Stercoralis Test
Strongyloides IgG ELISA
New
Cytomegalovirus Assay
Alethia CMV

Print article

Channels

Immunology

view channel
Image: Example image of the high-throughput microscopy method used in the study, showing immune cells stained with different fluorescence markers (Photo courtesy of Felix Kartnig/CeMM, MedUni Vienna)

Cutting-Edge Microscopy Technology Enables Tailored Rheumatology Therapies

Rheumatoid arthritis is the most common inflammatory joint disorder, with women three times as likely to suffer from the condition as men. Treatment advances made over the past decades have led to the... Read more

Microbiology

view channel
Image: RNA sequencing directly from whole blood aims to expand access to LRTI testing (Photo courtesy of CARB-X)

Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood

Pneumonia and lower-respiratory-tract infections (LRTIs) are among the top causes of illness and death globally, particularly in vulnerable populations such as the elderly, young children, and immunocompromised... Read more

Pathology

view channel
Image: The new method uses DNA sequencing to measure metabolites (Photo courtesy of 123RF)

New Metabolite Detection Method Using DNA Sequencing Could Transform Diagnostics

Metabolites play a vital role as biomarkers that provide insights into our health, and when their levels go awry, it can lead to diseases such as diabetes and phenylketonuria. Quantifying metabolites remains... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.